Indra vs Isomorphic Labs

Side-by-side comparison of features, pricing, and ratings

Analysis reviewed Live tool data as of 2026-10-18
Cross-checked through our multi-step verification ·
Saved

At a glance

DimensionIndraIsomorphic Labs
PricingFree (open-source)Contact (enterprise partnerships)
Target UserSystems biologists, bioinformaticians, computational pharmacologistsPharma companies and large-scale drug programs
Core ApproachAutomated model assembly from literature and databasesAI-first drug design via predictive and generative models
Integration10+ NLP readers, 20+ databases, REST API, DockerPartnership-based (e.g., Novartis, Johnson & Johnson)
Key StrengthKnowledge-level assembly with error correctionNobel Prize-winning AlphaFold foundation
Latest NewsOngoing open-source development, cost reduction focusSeries B in Feb 2026, J&J collaboration

Isomorphic Labs is for deep-pocketed pharma partners requiring large-scale, AI-driven drug design. Indra is a free, open-source framework for researchers who programmatically assemble mechanistic models. Choose Isomorphic for turnkey AI drug discovery; choose Indra for transparent, customizable model building.

Indra
Indra

Open-source Python framework that assembles causal and mechanistic models from literature and biological databases.

Visit Website
Isomorphic Labs
Isomorphic Labs

Isomorphic Labs uses AI drug discovery models to design novel molecules and predict how candidate drugs will perform.

Visit Website
Pricing
Free
Contact Sales
Plans
$0
—
Popularity
2 views
7.5k views
Skill Level
Advanced
Advanced
API Available
Platforms
APICLI
—
Categories
🧬 Drug Discovery & Life Sciences
🧬 Drug Discovery & Life Sciences
Features
Integration with NLP reading systems (REACH, TRIPS/DRUM, Sparser, Eidos, TEES, MedScan)
Additional readers including RLIMS-P, ISI/AMR, Geneways, GNBR, SemRep, textToKnowledgeGraph
Biological database importers (PathwayCommons/BioPAX, BioGRID, Signor, DrugBank, OmniPath)
Further database sources: HPRD, TRRUST, Phospho.ELM, VirHostNet, CTD, DGI, CRoG, CREEDS, UbiBrowser, ACSN, WormBase
Target Affinity Spectrum (TAS) importer for drug-target evidence
Custom knowledge base inputs (NDEx/CX, INDRA DB, Hypothes.is, Biofactoid, MINERVA)
Standardized INDRA Statements representation across all sources
Knowledge-level assembly: error correction, redundancy resolution, inference, scope filtering
Preassembler for resolving redundancy and contradiction between sources
BeliefEngine for confidence scoring of causal assertions
PySB assembler producing executable rule-based models via a policy-guided assembly procedure
Compilation of PySB models to SBML, SBGN, BNGL, and Kappa
PyBEL, IndraNet, SIF and KAMI assemblers for causal analysis and Kappa modeling
Visualization outputs: Graphviz, Cytoscape JS, SBGN, CX, SIF
Curation outputs: HTML, TSV, IndexCards
Drug Design Engine spanning generative molecule design through lead optimization
Predictive AI models that anticipate how candidate drugs will perform
Generative models for designing novel molecules
Built on and beyond the Nobel-winning AlphaFold system
End-to-end research collaborations from target identification to lead optimization
Digital biology approach aimed at discovery at digital speed
Named pharma partners include Johnson & Johnson, Novartis and Eli Lilly
Joined the Virtual Biology Initiative to build foundational data for AI disease models
Funder of Biohub's $1.8B initiative to train AI models that predict cell behavior
Bioresilience framework for biological threats and health emergencies
Announced a new path to making medicines with AI
Series B announced May 2026 to scale the Drug Design Engine
Follows a $600M external raise in March 2025
President Max Jaderberg appointed November 2025 to integrate AI and science
Founded by Demis Hassabis, who serves as CEO
Integrations
REACH
TRIPS/DRUM
Sparser
Eidos
TEES
MedScan
RLIMS-P
ISI/AMR
Geneways
GNBR
SemRep
PathwayCommons
BioGRID
Signor
DrugBank
OmniPath

What real users say: Indra vs Isomorphic Labs

Not marketing copy and not our opinion — a structured sweep of public discussion (reviews, forums, communities and video comments), showing what people praise and what they complain about for each tool.

Indra

48 mentions across 5 sources · 47% positive — mixed (averaged across 5 sources)

Hacker News, YouTube, Product Hunt, GitHub, Lemmy

What users praise

  • • Integrates 12+ NLP readers and 20+ databases into one standard format.
  • • Knowledge-level assembly resolves contradictions and filters by reliability.
  • • Exports to SBML, BNGL, SBGN, Graphviz, and human-readable summaries.
  • • Free, MIT-licensed, with full transparency versus commercial alternatives.

What frustrates them

  • • Steep learning curve — requires programming and systems biology expertise.
  • • No GUI; everything is command-line and Python-based.
  • • Documentation is extensive but could be overwhelming for newcomers.
  • • Setup can be complicated due to many dependencies and integrations.

Researched Aug 4, 2026

Isomorphic Labs

No verifiable community signal. We scanned public discussion on Oct 14, 2026 and found posts matching the name “Isomorphic Labs”, but could not establish that they are about this product rather than something else sharing its name. Rather than publish a score built on the wrong subject, we publish none.

Who should pick which

  • Pharma partnership lead
    Pick: Isomorphic Labs

    Best for large-scale, AI-driven drug development programs with established pharma collaborations.

  • Systems biology researcher
    Pick: Indra

    Free, open-source tool to build mechanistic models from literature and databases programmatically.

  • Computational pharmacologist
    Pick: Indra

    Leverage 10+ NLP systems and databases to study drug mechanisms at scale without licensing costs.

  • Startup with limited budget
    Pick: Indra

    No-cost entry point for automated model assembly, though requires Python expertise.

  • Executive at a large pharma company
    Pick: Isomorphic Labs

    Access to Nobel Prize-winning AI models and deep pharma partnership model for transformative drug design.

Frequently Asked Questions

Indra vs Isomorphic Labs: which should you choose?

Isomorphic Labs is for deep-pocketed pharma partners requiring large-scale, AI-driven drug design. Indra is a free, open-source framework for researchers who programmatically assemble mechanistic models. Choose Isomorphic for turnkey AI drug discovery; choose Indra for transparent, customizable model building.

Is Isomorphic Labs available for individual researchers?

No, Isomorphic Labs operates only through pharma partnerships; no direct software or API access is offered.

Is Indra free to use?

Yes, Indra is open-source and free, with a REST API and Docker deployment options.

Does Isomorphic Labs provide a graphical interface?

No, it is a partnership-based service; there is no standalone software UI.

Can Indra be used without programming?

No, Indra is a Python framework requiring scripting experience; no GUI is available.

What is the latest funding news for Isomorphic Labs?

Isomorphic Labs closed a Series B investment round in February 2026 (details undisclosed) and raised $600M in 2025.

What databases does Indra integrate with?

Indra integrates with over 20 databases including PathwayCommons, BioGRID, and DrugBank.

Can Isomorphic Labs be used for drug repurposing?

It is not intended for short-term repurposing; it focuses on novel molecule design and large-scale programs.

Does Indra support non-molecular domains?

Yes, via the INDRA World extension, it can be applied to epidemiological modeling (EMMAA) and other domains.

More Indra or Isomorphic Labs comparisons

Explore each tool further

Browse these categories

Still deciding? Get the weekly AI tools brief

One email a week — new tools, honest comparisons, no spam.

Last reviewed: July 5, 2026